Haematology 2018

HD8: Second Neoplasia

0.4

EF

IF

15-year estimate [95%-CI] EF: 17.1% [13.2% to 21.1%] IF: 14.2% [10.4% to 18.1%] diff: -2.9% [-8.4% to 2.6%] Median observation time 153 months

0.3

0.2716 p =

0.2

0.1

Cumulative incidence +/- 95%-CI

0.0

0 12 24 36 48 60 72 84 96 108 120 132 144 156 168 180 192 204 216 228 240

Time [months]

Pts. at risk

532 532

426 423

288 261

151 134

16 11

→ Trend towards increased SIR with EF: 3.6 (2.9-4.0) vs. 2.6 (2.0-3.3) compared to the age- and sex-specific incidence in the German general population

Bröckelmann et al; EHA 2016